NCT07720622 Comparison of Motor Relearning Program and Electric Muscle Stimulation in Subacute Stroke Patients
| NCT ID | NCT07720622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montiha Azeem |
| Condition | Subacute Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2026-09-06 |
| Primary Completion | 2026-09-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2026-09-06 with a primary completion date of 2026-09-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke is one of the leading causes of long-term disability worldwide, with upper limb motor impairment being a common consequence that limits independence in activities of daily living. The Motor Relearning Program (MRP) is a task-oriented rehabilitation approach designed to improve motor recovery through repetitive functional practice. Electrical Muscle Stimulation (EMS) may further enhance muscle activation and facilitate motor recovery when combined with conventional rehabilitation. The purpose of this single-blinded randomized controlled trial is to compare the effectiveness of the Motor Relearning Program combined with Electrical Muscle Stimulation versus the Motor Relearning Program alone in improving upper limb function in individuals with subacute stroke. Thirty-six eligible participants with subacute stroke will be randomly allocated into two groups. Group A will receive MRP together with EMS, while Group B will receive the same MRP without EMS. Both groups will undergo treatment for 1 hour per day, 5 days per week, for 6 weeks. Upper limb motor recovery and muscle tone will be evaluated at baseline and after the intervention using the Upper Extremity Fugl-Meyer Assessment (UEFMA), Modified Ashworth Scale (MAS), and Motor Evaluation Scale for Upper Extremity in Stroke (MESUPES). The findings of this study may help determine whether adding EMS to a structured Motor Relearning Program provides greater improvements in upper limb function than MRP alone in individuals with subacute stroke.
Eligibility Criteria
Inclusion Criteria: * Age 40-65 years * Both male and female * Sub acute stroke patients diagnosed by neurologist * Motor assessment scale score 2-3 * Subjects able to sit for 30 secs without using upper extremities for support. * Modified Ashworth scale value \< 2 Exclusion Criteria: * Patients with Mini Mental State Examination \<23 * Cognitive disorders and perceptual disorders * Any musculoskeletal disorders * Severe cardiac diseases
Contact & Investigator
Laraib Gull, MSPTN
PRINCIPAL INVESTIGATOR
The University of Lahore, Lahore
Frequently Asked Questions
Who can join the NCT07720622 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Subacute Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07720622 currently recruiting?
Yes, NCT07720622 is actively recruiting participants. Contact the research team at laraibgull9697@gmail.com for enrollment information.
Where is the NCT07720622 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07720622 clinical trial?
NCT07720622 is sponsored by Montiha Azeem. The principal investigator is Laraib Gull, MSPTN at The University of Lahore, Lahore. The trial plans to enroll 36 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.